Business Mylan-Lupin tie up on Etanercept, what does it mean for Biocon Updated : June 29, 2018 02:56 PM IST Lupin is expected to be the third or fourth company to enter the European Union (EU) market for Enbrel according to Morgan Stanley. For the US, experts expect the Etanercept market to only open up a few years down the line, hence the street will watch how Mylan and Biocon could monetise it. Subscribe to Moneycontrol PRO at just Rs.33/- per month for the first year. Use code SUPERPRO. Limited period offer. Available on Web and Android.